Search
Descriptor English: Rituximab
Descriptor Spanish: Rituximab
Descriptor rituximab
Scope note: Anticuerpo monoclonal de origen murino y AGENTE ANTINEOPLÁSICO que se une específicamente al ANTÍGENO CD20 y se utiliza en el tratamiento de la LEUCEMIA ; LINFOMA y ARTRITIS REUMATOIDE.
Descriptor Portuguese: Rituximab
Descriptor French: Rituximab
Entry term(s): CD20 Antibody, Rituximab
GP2013
IDEC C2B8
IDEC C2B8 Antibody
IDEC-C2B8
IDEC-C2B8 Antibody
Mabthera
Rituxan
Rituximab CD20 Antibody
Tree number(s): D12.776.124.486.485.114.224.075.785
D12.776.124.790.651.114.224.075.785
D12.776.377.715.548.114.224.284.785
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069283
Scope note: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
DE drug effects
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Pharm Action: Antineoplastic Agents, Immunological
Immunologic Factors
Antirheumatic Agents
Registry Number: 4F4X42SYQ6
Public MeSH Note: 2016; RITUXIMAB was indexed under ANTIBODIES, MONOCLONAL, MURINE-DERIVED 1995-2016
History Note: 2016 (1995)
Related: Antigens, CD20 MeSH
DeCS ID: 55982
Unique ID: D000069283
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2017/06/20
Rituximab - Preferred
Concept UI M0244307
Scope note A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
Preferred term Rituximab
Entry term(s) CD20 Antibody, Rituximab
Rituximab CD20 Antibody
Mabthera - Narrower
Concept UI M0445644
Preferred term Mabthera
IDEC-C2B8 Antibody - Narrower
Concept UI M0244308
Preferred term IDEC-C2B8 Antibody
Entry term(s) IDEC C2B8
IDEC C2B8 Antibody
IDEC-C2B8
GP2013 - Narrower
Concept UI M000603610
Preferred term GP2013
Rituxan - Narrower
Concept UI M0244306
Preferred term Rituxan



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey